174 related articles for article (PubMed ID: 23218864)
1. Intravitreal ranibizumab for type 3 choroidal neovascularization complicating adult onset foveomacular vitelliform dystrophy.
Querques G; Querques L; Leveziel N; Bandello F; Souied EH
J Fr Ophtalmol; 2013 Jan; 36(1):e1-4. PubMed ID: 23218864
[TBL] [Abstract][Full Text] [Related]
2. Ranibizumab for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy: one-year results.
Mimoun G; Caillaux V; Querques G; Rothschild PR; Puche N; Souied EH
Retina; 2013 Mar; 33(3):513-21. PubMed ID: 23400081
[TBL] [Abstract][Full Text] [Related]
3. [Intravitreal ranibizumab for choroidal neovascularisation associated with adult-onset vitelliform dystrophy].
Prieto-Calvo E; Torrón-Fernández Blanco C; Egea-Estopiñán C; Güerri-Monclús N; Ferrer-Novella E; Ruiz-Moreno O; Pablo-Julvez LE
Arch Soc Esp Oftalmol; 2012 May; 87(5):149-52. PubMed ID: 22554558
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.
Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N
Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461
[TBL] [Abstract][Full Text] [Related]
5. Functional and anatomic changes in bilateral choroidal neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab.
Cennamo G; Cesarano I; Vecchio EC; Reibaldi M; de Crecchio G
J Ocul Pharmacol Ther; 2012 Dec; 28(6):643-6. PubMed ID: 22742532
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of intravitreal ranibizumab for choroidal neovascularization secondary to Best's disease: 3-year follow-up.
Ruiz-Moreno O; Calvo P; Ferrández B; Torrón C
Acta Ophthalmol; 2012 Nov; 90(7):e574-5. PubMed ID: 22339886
[No Abstract] [Full Text] [Related]
7. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report.
Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D
Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013
[TBL] [Abstract][Full Text] [Related]
8. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
[TBL] [Abstract][Full Text] [Related]
9. Primary intravitreal ranibizumab for adult-onset foveomacular vitelliform dystrophy.
Gallego-Pinazo R; Dolz-Marco R; Pardo-López D; Arevalo JF; Díaz-Llopis M
Graefes Arch Clin Exp Ophthalmol; 2011 Mar; 249(3):455-8. PubMed ID: 20931215
[TBL] [Abstract][Full Text] [Related]
10. Bevacizumab treatment for choroidal neovascularization associated with adult-onset foveomacular vitelliform dystrophy.
Tiosano L; Jaouni T; Averbukh E; Grunin M; Banin E; Chowers I
Eur J Ophthalmol; 2014; 24(6):890-6. PubMed ID: 24846624
[TBL] [Abstract][Full Text] [Related]
11. Type 3 choroidal neovascularization associated with fundus flavimaculatus.
Quijano C; Querques G; Massamba N; Soubrane G; Souied EH
Ophthalmic Res; 2009; 42(3):152-4. PubMed ID: 19628956
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child.
Chhablani J; Jalali S
Eur J Ophthalmol; 2012; 22(4):677-9. PubMed ID: 22139615
[TBL] [Abstract][Full Text] [Related]
13. [Intravitreal ranibizumab injection for the treatment of idiopathic choroidal neovascularisation in young patients].
Ouhadj O; Degheb N; Idir S; Nebab A; Nouri MT
J Fr Ophtalmol; 2012 Sep; 35(7):514-22. PubMed ID: 22789650
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal ranibizumab for choroidal neovascularization associated with retinal astrocytic hamartoma.
Querques G; Kerrate H; Leveziel N; Coscas G; Soubrane G; Souied EH
Eur J Ophthalmol; 2010; 20(4):789-91. PubMed ID: 20213614
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
17. Adult-onset vitelliform detachment unresponsive to monthly intravitreal ranibizumab.
Kandula S; Zweifel S; Freund KB
Ophthalmic Surg Lasers Imaging; 2010; 41 Suppl():S81-4. PubMed ID: 21117608
[TBL] [Abstract][Full Text] [Related]
18. Optical Coherence Tomography Angiography of a Choroidal Neovascularization in Adult Onset Foveomacular Vitelliform Dystrophy: Pearls and Pitfalls.
Lupidi M; Coscas G; Cagini C; Coscas F
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7638-45. PubMed ID: 26624495
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia.
Lalloum F; Souied EH; Bastuji-Garin S; Puche N; Querques G; Glacet-Bernard A; Coscas G; Soubrane G; Leveziel N
Retina; 2010 Mar; 30(3):399-406. PubMed ID: 20038864
[TBL] [Abstract][Full Text] [Related]
20. [Intravitreal bevacizumab treatment for choroidal neovascularization in Best's disease].
Perol J; Wolff B; Sahel JA; Le Mer Y
J Fr Ophtalmol; 2011 May; 34(5):281-6. PubMed ID: 21507509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
